United Therapeutic
(UTHR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2015 | 06-2015 | 03-2015 | 12-2014 | 09-2014 | |
| Sales | 386,200 | 347,200 | 327,500 | 346,345 | 329,950 |
| Cost of Goods | 6,900 | 16,000 | 20,800 | 15,788 | 40,803 |
| Gross Profit | 379,300 | 331,200 | 306,700 | 330,557 | 289,147 |
| Operating Expenses | -6,800 | 159,400 | 322,300 | 152,769 | 322,186 |
| Operating Income | 387,000 | 171,800 | -14,800 | 178,576 | -32,236 |
| Interest Expense | 800 | 1,300 | 2,100 | 3,535 | 4,709 |
| Other Income | 350,600 | -2,100 | 100 | -257 | 1,112 |
| Pre-tax Income | 736,800 | 168,400 | -16,800 | 174,784 | -35,833 |
| Income Tax | 272,400 | 69,200 | -200 | 58,823 | -10,596 |
| Net Income Continuous | 464,400 | 99,200 | -16,600 | 115,961 | -25,237 |
| Net Income | $464,400 | $99,200 | $-16,600 | $115,961 | $-25,237 |
| EPS Basic Total Ops | 10.20 | 2.15 | -0.36 | 2.51 | -0.53 |
| EPS Basic Continuous Ops | 10.21 | 2.15 | -0.36 | 2.51 | -0.53 |
| EPS Diluted Total Ops | 9.24 | 1.91 | -0.36 | 2.28 | -0.53 |
| EPS Diluted Continuous Ops | 9.25 | 1.91 | -0.36 | 2.28 | -0.53 |
| EBITDA(a) | $388,800 | $183,700 | $-3,500 | $173,300 | $-19,486 |